N ‐ Benzyl ‐ N ‐ (1 ‐ phenylethyl)cyclohexanamine

: The preparation and characterization of a new chiral tertiary dibenzylamine are described. These molecules are well known in the literature for their high neuropharmacological potential. The general synthetic pathway is based on asymmetric Aza–Michael addition of chiral ( R )- N -benzyl- N - ( α -methylbenzyl)amide to methyl cyclohex-1-en-carboxilate obtaining the β -amino ester, followed by carboxylic acid hydrolysis and subsequent Barton descarboxylation. Interestingly, it is a general synthetic procedure of a wide range of chiral amines by careful choice of insaturated esters and alkylation of the chiral enolate in the initial reaction. The new tertiary dibenzylamine molecule is fully characterized by NMR Spectroscopy ( 1 H and 13 C), as well by High-Resolution Mass Spectrometry and Infrared Spectroscopy.


Introduction
The favorable physiological properties of dibenzylamines and their capability to interfere with natural neurotransmission pathways make these structures attractive for the treatment of neurodegenerative disorders, such as Alzheimer's disease [1].Several in silico studies and in vitro assays [2][3][4] have shown how these motifs are embedded in more complex molecular constructs with key drug-like properties (even hybrid molecules), such as neuronal regeneration and blocking neurodegeneration [5,6].This represents a very powerful strategy to obtain drugs targeting complex pathologies [7].N-methyl-dibenzylamine derivative (Scheme 1) is an important tertiary inhibitor of human AChE/BuChE (Acetylcholineristerase and Butylcholinestarase) and, in addition, acts as a pure competitive inhibitor, since it binds to the central active site (CAS) of the enzyme [8].

Introduction
The favorable physiological properties of dibenzylamines and their capability to interfere with natural neurotransmission pathways make these structures attractive for the treatment of neurodegenerative disorders, such as Alzheimer's disease [1].Several in silico studies and in vitro assays [2][3][4] have shown how these motifs are embedded in more complex molecular constructs with key drug-like properties (even hybrid molecules), such as neuronal regeneration and blocking neurodegeneration [5,6].This represents a very powerful strategy to obtain drugs targeting complex pathologies [7].N-methyldibenzylamine derivative (Scheme 1) is an important tertiary inhibitor of human AChE/BuChE (Acetylcholineristerase and Butylcholinestarase) and, in addition, acts as a pure competitive inhibitor, since it binds to the central active site (CAS) of the enzyme [8]. of AChE/BuChE.This paper also presents the characterization of this new potential ligand 1 by different analytical techniques, such as proton and carbon NMR, mass spectrometry and infrared spectroscopy.
This paper describes the preparation and characterization of chiral tertiary dibenzylamine (R)-N-benzyl-N-(1-phenylethyl)cyclohexanamine (1), which features a cyclohexyl group replacing the methyl group in the AChE-CAS core group as a potential new ligand of AChE/BuChE.This paper also presents the characterization of this new potential ligand 1 by different analytical techniques, such as proton and carbon NMR, mass spectrometry and infrared spectroscopy.

Materials and Methods
All reagents were purchased from commercial suppliers and used as received without further purification, except for solvents used for flash chromatography.The (1R,2R)-2-(benzyl((R)-1-phenylethyl)amino)cyclohexane-1-carboxylic acid (5) was prepared by a method adapted from the literature (Supplementary Material). 1 H and 13 C NMR spectra

Materials and Methods
All reagents were purchased from commercial suppliers and used as received without further purification, except for solvents used for flash chromatography.The (1R,2R)-2-(benzyl((R)-1-phenylethyl)amino)cyclohexane-1-carboxylic acid (5) was prepared by a method adapted from the literature (Supplementary Material). 1 H and 13 C NMR spectra were recorded on a Bruker Advance Neo at 400 MHz using CDCl 3 as a solvent.Infrared spectrum was recorded on a Shimazdu IR Affinity-1 spectrophotometer, using capillary film on KCl crystals.Specific rotation measurements were carried out on a Perkin-Elmer 241 digital polarimeter in 1 dm optical step cuvettes and in chloroform solution.Mass spectra were recorded at a quadruple-time-of-flight (QTOF) spectrometer from Applied Biosystems QSTAR XL, under conditions of ionization by electrospray (ESI), APCI and photospray.Column chromatographies (CC) were performed on glass columns, packed with Merck-60 silica gel (particle size 0.063-0.200mm) and the initial eluent.Eluents were prepared with solvent mixtures of increasing polarity (usually Hexane/AcOEt mixtures), which changed as the chromatography progressed and were followed by TLC on 0.2 mm thick Merck silica gel plates (60 F254).Fluorescent substances were directly visualized by illumination with ultraviolet light of λ = 254 nm.

Conclusions
A useful method for the enantioselective synthesis of (R)-N-benzyl-N-(1-phenylethyl) cyclohexanamine ( 1) is described.By applying the Barton descarboxylation described protocol to (1R,2R)-2-(benzyl((R)-1-phenylethyl)amino)cyclohexane-1-carboxylic acid 5, the chiral tertiary dibenzylamine 1 was obtained in 50% yield.It is important to note that this β-amino acid 5 was obtained in 90% overall yield from affordable methylcyclohexene carboxylate 4. The methodology is applicable to the synthesis of a wide range of tertiary dibenzyl amines.Current extension to other substrates is in progress and the results will be published in due course.
Tertiary dibenzyl amines have proven appealing neuropharmacological properties.With the present description, we propose a novel, accessible transformation to elaborate a great variety of similar analogues by careful choice of starting materials and alkylation of the initial enolate.

Scheme 2 .
Scheme 2. Reaction scheme of 1; (a) 1: 2,2'-dithiobis pyridine-N-oxide (6), Ph3P, THF; 2: tBuSH, h The molecular structure of compound 1 was confirmed by different analytical techniques (Supplementary Materials).First, the 1 H NMR spectrum exhibited characteristic peaks for Michael adduct compounds, such as the quartet at δ (ppm) = 3.99 (J = 6.8 Hz) for benzylic proton (H-1′); the doublets for SAB benzylic protons (H-1′'a and H-1′'b) at δ (ppm) = 3.81 and 3.71, respectively (J = 15.1 Hz), and the low-field doublet for α-Me at δ (ppm) = 1.33 (J = 6.8 Hz).Moreover, the signal triple triplet at δ (ppm) = 2.55 (J = 11.5, 3.3 Hz) corresponded to the H-1 hydrogen.The 13 C NMR spectrum accounted for peaks of the overall 21 C atoms of the molecule as expected, highlighting associated signals of the three C atoms bonded to N at δ (ppm) = 57.38,57.28 (CH-N) and 50.21 (CH2-N).The results of the 1 H-13 C heteronuclear correlation experiments (standard and long-range HSQC and HMBC; Supplementary Materials) allowed us to corroborate their structure and the full assignment of the 1 H and 13 C data.The infrared spectrum featured C-N stretching vibrations for alkyl-amine C-N at 1261 and 1026 cm −1 , and C-N stretch bands for benzylamines at 1371 cm −1 .Molecular composition was further confirmed by MS (ESI), indicating a measured m/z of 294.2214, which was coherent with the calculated mass for the molecular ion [C21H27N + H] + (m/z = 294.2216).

Scheme 2 .
Scheme 2. Reaction scheme of 1; (a) 1: 2,2 -dithiobis pyridine-N-oxide (6), Ph 3 P, THF; 2: tBuSH, hυ.The molecular structure of compound 1 was confirmed by different analytical techniques (Supplementary Materials).First, the 1 H NMR spectrum exhibited characteristic peaks for Michael adduct compounds, such as the quartet at δ (ppm) = 3.99 (J = 6.8 Hz) for benzylic proton (H-1 ); the doublets for SAB benzylic protons (H-1 a and H-1 b) at δ (ppm) = 3.81 and 3.71, respectively (J = 15.1 Hz), and the low-field doublet for α-Me at δ (ppm) = 1.33 (J = 6.8 Hz).Moreover, the signal triple triplet at δ (ppm) = 2.55 (J = 11.5, 3.3 Hz) corresponded to the H-1 hydrogen.The 13 C NMR spectrum accounted for peaks of the overall 21 C atoms of the molecule as expected, highlighting associated signals of the three C atoms bonded to N at δ (ppm) = 57.38,57.28 (CH-N) and 50.21 (CH 2 -N).The results of the 1 H-13 C heteronuclear correlation experiments (standard and long-range HSQC and HMBC; Supplementary Materials) allowed us to corroborate their structure and the full assignment of the 1 H and 13 C data.The infrared spectrum featured C-N stretching vibrations for alkyl-amine C-N at 1261 and 1026 cm −1 , and C-N stretch bands for benzylamines at 1371 cm −1 .Molecular composition was further confirmed by MS (ESI), indicating a measured m/z of 294.2214, which was coherent with the calculated mass for the molecular ion [C 21 H 27 N + H] + (m/z = 294.2216).